Metformin and Pancreatic Cancer Risk in Patients with Type 2 Diabetes
Journal
Pancreas
Journal Volume
47
Journal Issue
9
Pages
e57-e59
Date Issued
2018
Author(s)
SDGs
Other Subjects
acarbose; acetylsalicylic acid; adenylate kinase; calcium channel blocking agent; dipeptidyl carboxypeptidase inhibitor; fibric acid derivative; hydroxymethylglutaryl coenzyme A reductase inhibitor; insulin; liver enzyme; liver kinase b1; meglitinide; metformin; pioglitazone; rosiglitazone; sulfonylurea; transcription factor; unclassified drug; antidiabetic agent; metformin; age; algorithm; apoptosis; autophagy; cancer diagnosis; cancer incidence; cancer inhibition; cancer risk; cerebrovascular accident; cholesterol synthesis; chronic disease; chronic obstructive lung disease; diabetic patient; down regulation; drug cost; drug exposure; dyslipidemia; eye disease; fatty acid synthesis; gene overexpression; geographic distribution; Helicobacter infection; human; hypertension; ICD-9-CM; immune system; ischemic heart disease; kidney disease; Letter; lowest income group; medical history; meta analysis (topic); mitosis inhibition; non insulin dependent diabetes mellitus; obesity; occupation; pancreas cancer; peripheral occlusive artery disease; prescription; priority journal; propensity score; proto oncogene; sex; signal transduction; social status; Taiwanese; tobacco dependence; veteran; complication; incidence; non insulin dependent diabetes mellitus; pancreas tumor; propensity score; risk factor; Taiwan; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Incidence; Metformin; Pancreatic Neoplasms; Propensity Score; Risk Factors; Taiwan
Publisher
Lippincott Williams and Wilkins
Type
letter